EXHIBIT 107

 

Calculation of Filing Fee Tables

 

Form S-1

(Form Type)

 

Artelo Biosciences, Inc.

(Exact Name of Registrant as Specified in its Charter)

 

Table 1: Newly Registered Securities

 

 

Security

Type

Security

Class

Title

Fee

Calculation

Rule

Amount

Registered (1)

Proposed Maximum Offering

Price Per

Unit (2)

Maximum

Aggregate

Offering

Price

Fee

Rate

Amount of

Registration

Fee

Newly Registered Securities

Fees to Be Paid

Equity

Common stock, par value $0.001 per share, or pre-funded warrants to purchase shares of common stock, par value $0.001, per share

457(c)

81,000

$6.53

$528,930.00

0.00013810

$73.05

Fees to Be Paid

Equity

Common stock, par value $0.001 per share, issuable upon exercise of pre-funded warrants

457(c)

3,107,407

$6.53

$20,291,367.71

0.00013810

$2,802.24

Fees to Be Paid

Equity

Common stock, par value $0.001 per share, issuable upon exercise of common warrants

457(c)

6,376,814

$6.53

$41,640,595.42

0.00013810

$5,750.57

Fees to Be Paid

Equity

Common stock, par value $0.001 per share, issuable upon exercise of placement agent warrants

457(c)

255,073

$6.53

$1,665,626.69

0.00013810

$230.02

 

 

 

 

 

 

 

 

 

 

Total Offering Amounts

 

$64,126,519.82

 

$8,855.88

 

Total Fees Previously Paid

 

 

 

-

 

Total Fee Offsets

 

 

 

$1,789.78

 

Net Fee Due

 

 

 

$7,066.10

 

(1)

Pursuant to Rule 416(a) of the Securities Act of 1933, as amended, this registration statement shall also cover any additional shares of the registrant’s common stock, par value $0.001 per share (the “Common Stock”), that become issuable by reason of any stock dividend, stock split, recapitalization or other similar transaction effected without receipt of consideration that increases the number of the registrant’s outstanding shares of common stock.

 

 

(2)

Estimated solely for the purpose of calculating the registration fee pursuant to Rule 457(c) under the Securities Act based on the average of the high and low prices of the registrant’s common stock on the Nasdaq Capital Market on April 6, 2026.

 

 
1

 

 

Table 2: Fee Offset Claims and Sources

 

 

Registrant or

Filer Name

Form or

Filing Type

File Number

Initial Filing Date

Filing Date

Fee Offset Claimed

Security Type Associated

with Fee

Offset

Claimed

Security Title

Associated

with Fee

Offset

Claimed

Unsold Securities

Associated

with Fee

Offset

Claimed

Unsold Aggregate

Offering

Amount

Associated

with Fee

Offset

Claimed

Fee Paid with Fee Offset

Source

Rule 457(p)

Fee Offset Claims

Artelo Biosciences, Inc.

Form S-1(1)

333-294506

March 20, 2026

$1,789.78

Equity

Common stock, par value $0.001 per share, and related securities

-

$12,960,000

Fee Offset Sources

Artelo Biosciences, Inc.

Form S-1(1)

333-294506

March 20, 2026

 

 

 

 

 

$1,789.78

 

(1)

The Registrant previously paid filing fees of $1,789.78 in connection with the Registration Statement on Form F-1 (File No. 333-294506) (the “Prior Registration Statement”) filed on March 20, 2026, which Prior Registration Statement was withdrawn on March 27, 2026, pursuant to Rule 477 under the Securities Act. No securities were sold under the Prior Registration Statement before it was withdrawn. In accordance with Rule 457(p) under the Securities Act, the total amount of the registration fee due upon the initial filing of this Registration Statement is offset by $1,789.78, representing the fee paid in connection with the Prior Registration Statement.

 

 

2